Exact Sciences Corp (EXAS):企業の財務・戦略的SWOT分析

【英語タイトル】Exact Sciences Corp (EXAS) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C2479)・商品コード:DATA904C2479
・発行会社(調査会社):GlobalData
・発行日:2018年7月
・ページ数:39
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,875見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,625見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Exact Sciences Corp (EXAS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of colorectal cancer and pre-cancer. It utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer. The company is also working on the development of additional tests for other types of cancers and identified proprietary methylation markers for several major cancers. It operates laboratory facilities in Madison, Wisconsin to process Cologuard tests. Exact Sciences is headquartered in Madison, Wisconsin, the US.

Exact Sciences Corp Key Recent Developments

Jun 07,2018: Exact Sciences Announces Offering of 1.0% Convertible Senior Notes Due 2025
Jun 05,2018: Mayo Clinic researchers take a step closer to developing a DNA test for liver cancer
Jun 05,2018: Exact Sciences, Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel to Accurately Diagnose Hepatocellular Carcinoma
Jan 07,2018: Exact Sciences to report $265.5-266.5 million in revenue, 168 percent growth for 2017
Jul 25,2017: Cologuard revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Exact Sciences Corp – Key Facts 5
Exact Sciences Corp – Key Employees 6
Exact Sciences Corp – Key Employee Biographies 8
Exact Sciences Corp – Major Products and Services 9
Exact Sciences Corp – History 10
Exact Sciences Corp – Company Statement 12
Exact Sciences Corp – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
Exact Sciences Corp – Business Description 16
R&D Overview 16
Exact Sciences Corp – Corporate Strategy 17
Exact Sciences Corp – SWOT Analysis 18
SWOT Analysis – Overview 18
Exact Sciences Corp – Strengths 18
Exact Sciences Corp – Weaknesses 19
Exact Sciences Corp – Opportunities 20
Exact Sciences Corp – Threats 21
Exact Sciences Corp – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
Exact Sciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 29
Exact Sciences Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 30
Exact Sciences Corp, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Jan 07, 2018: Exact Sciences to report $265.5-266.5 million in revenue, 168 percent growth for 2017 32
Jul 25, 2017: Cologuard revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests 33
Feb 21, 2017: Exact Sciences reports lower Q4 net loss, provides outlook for 2017 34
Section 6 – Appendix 35
Methodology 35
Ratio Definitions 35
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Exact Sciences Corp, Key Facts 5
Exact Sciences Corp, Key Employees 6
Exact Sciences Corp, Key Employee Biographies 8
Exact Sciences Corp, Major Products and Services 9
Exact Sciences Corp, History 10
Exact Sciences Corp, Subsidiaries 14
Exact Sciences Corp, Key Competitors 22
Exact Sciences Corp, Ratios based on current share price 23
Exact Sciences Corp, Annual Ratios 24
Exact Sciences Corp, Annual Ratios (Cont...1) 25
Exact Sciences Corp, Interim Ratios 27
Exact Sciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 29
Exact Sciences Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 30
Exact Sciences Corp, Recent Deals Summary 31
Currency Codes 35
Capital Market Ratios 35
Equity Ratios 36
Profitability Ratios 36
Cost Ratios 37
Liquidity Ratios 37
Leverage Ratios 38
Efficiency Ratios 38

List of Figures
Exact Sciences Corp, Performance Chart (2013 - 2017) 26
Exact Sciences Corp, Ratio Charts 28
Exact Sciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 29
Exact Sciences Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 30

★調査レポート[Exact Sciences Corp (EXAS):企業の財務・戦略的SWOT分析] (コード:DATA904C2479)販売に関する免責事項を必ずご確認ください。
★調査レポート[Exact Sciences Corp (EXAS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆